Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alx Oncology Holdings (ALXO) Interest Expenses (2019 - 2026)

Alx Oncology Holdings' Interest Expenses history spans 4 years, with the latest figure at $415000.0 for Q4 2023.

  • On a quarterly basis, Interest Expenses rose 79.65% to $415000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $1.6 million, a 557.56% increase, with the full-year FY2025 number at $1.6 million, down 7.35% from a year prior.
  • Interest Expenses hit $415000.0 in Q4 2023 for Alx Oncology Holdings, up from $391000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for ALXO hit a ceiling of $415000.0 in Q4 2023 and a floor of -$5000.0 in Q4 2020.
  • Historically, Interest Expenses has averaged $170538.5 across 4 years, with a median of $111000.0 in 2020.
  • Biggest five-year swings in Interest Expenses: plummeted 600.0% in 2020 and later soared 19450.0% in 2023.
  • Tracing ALXO's Interest Expenses over 4 years: stood at $1000.0 in 2019, then plummeted by 600.0% to -$5000.0 in 2020, then surged by 4720.0% to $231000.0 in 2022, then soared by 79.65% to $415000.0 in 2023.
  • Business Quant data shows Interest Expenses for ALXO at $415000.0 in Q4 2023, $391000.0 in Q3 2023, and $372000.0 in Q2 2023.